Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration
Authors:
- Yukie TanakaYTYukie Tanaka
- Kyaw Thu AungKAKyaw Thu Aung
- Mitsuaki OnoMOMitsuaki Ono
- Akihiro MikaiAMAkihiro Mikai
- Anh Tuan DangAnh Tuan Dang
- Emilio Satoshi HaraEHEmilio Satoshi Hara
- Ikue TosaITIkue Tosa
- Kei IshibashiKIKei Ishibashi
- Aya Ono-KimuraAOAya Ono-Kimura
- Kumiko NawachiKNKumiko Nawachi
- Takuo KubokiTKTakuo Kuboki
- Toshitaka OohashiTOToshitaka Oohashi
Open Access
- 26 November 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (23) , 12823
Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is related to impaired bone healing conditions in the maxillomandibular bone region as a complication of bisphosphonate intake. Although there are several hypotheses for the onset of MRONJ symptoms, one of the possible causes is the inhibition of bone turnover and blood supply leading to bone necrosis. The optimal treatment strategy for MRONJ has not been established either. BMP-2, a member of the TGF-β superfamily, is well known for regulating bone remodeling and homeostasis prenatally and postnatally. Therefore, the objectives of this study were to evaluate whether cyclophosphamide/zoledronate (CY/ZA) induces necrosis of the bone surrounding the tooth extraction socket, and to examine the therapeutic potential of BMP-2 in combination with the hard osteoinductive biomaterial, β-tricalcium phosphate (β-TCP), in the prevention and treatment of alveolar bone loss around the tooth extraction socket in MRONJ-like mice models. First, CY/ZA was intraperitoneally administered for three weeks, and alveolar bone necrosis was evaluated before and after tooth extraction. Next, the effect of BMP-2/β-TCP was investigated in both MRONJ-like prevention and treatment models. In the prevention model, CY/ZA was continuously administered for four weeks after BMP-2/β-TCP transplantation. In the treatment model, CY/ZA administration was suspended after transplantation of BMP-2/β-TCP. The results showed that CY/ZA induced a significant decrease in the number of empty lacunae, a sign of bone necrosis, in the alveolar bone around the tooth extraction socket after tooth extraction. Histological analysis showed a significant decrease in the necrotic alveolar bone around tooth extraction sockets in the BMP-2/β-TCP transplantation group compared to the non-transplanted control group in both MRONJ-like prevention and treatment models. However, bone mineral density, determined by micro-CT analysis, was significantly higher in the BMP-2/β-TCP transplanted group than in the control group in the prevention model only. These results clarified that alveolar bone necrosis around tooth extraction sockets can be induced after surgical intervention under CY/ZA administration. In addition, transplantation of BMP-2/β-TCP reduced the necrotic alveolar bone around the tooth extraction socket. Therefore, a combination of BMP-2/β-TCP could be an alternative approach for both prevention and treatment of MRONJ-like symptoms.Keywords
Funding Information
- Japan Society for the Promotion of Science (19H03842, 19K10246, 19K24146)
This publication has 53 references indexed in Scilit:
- The TGFbeta Superfamily Signaling PathwayWIREs Developmental Biology, 2012
- Bisphosphonates: The first 40yearsBone, 2011
- The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization.Journal of Orthopaedic Surgery and Research, 2011
- Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial SurgeonsJournal of Bone and Mineral Metabolism, 2010
- Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processingJournal of Bone and Mineral Metabolism, 2009
- American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast CancerJournal of Clinical Oncology, 2003
- Effect of rhBMP‐2 on guided bone regeneration in humansClinical Oral Implants Research, 2003
- Recombinant Human Bone Morphogenetic Protein‐2 Stimulation of Bone Formation Around Endosseous Dental ImplantsJournal of Periodontology, 1999
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996